ZyVersa Therapeutics entered into a warrant exercise inducement offer letter agreement with a certain holder of outstanding Series A and Series B Common Stock purchase warrants, with reduced exercise price and issuance of new warrants.
AI Assistant
ZYVERSA THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.